1
A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL
Condition(s):B-cell Non-Hodgkin’s LymphomaLast Updated:March 18, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):B-cell Non-Hodgkin’s LymphomaLast Updated:March 18, 2024Not yet recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:May 19, 2023Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:May 19, 2023Recruiting
Condition(s):Systemic Lupus Erythematosus; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Idiopathic Inflammatory Myopathies; Systemic SclerosisLast Updated:March 18, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.